Skip to main content
Top
Published in: World Journal of Urology 5/2016

01-05-2016 | Original Article

Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study

Authors: T. Grimm, A. Buchner, B. Schneevoigt, A. Kretschmer, M. Apfelbeck, M. Grabbert, J. F. Jokisch, C. G. Stief, A. Karl

Published in: World Journal of Urology | Issue 5/2016

Login to get access

Abstract

Purpose

Different blood parameters have shown to be associated with patient’s oncological outcome. There is only limited knowledge about the prognostic relevance of routine blood parameters in patients undergoing radical cystectomy for transitional cell carcinoma (TCC). Therefore, we retrospectively analyzed the influence of preoperative C-reactive protein (CRP) and hemoglobin (Hb) levels on overall survival (OS) and cancer-specific survival (CSS).

Materials and methods

Preoperative CRP and Hb levels were available in 664 patients who underwent RC due to TCC from 2004 to 2013 at our institution. More men than women (77 vs. 23 %) underwent surgery with a median age of 70 years (35–97). Median follow-up time was 24 months (max. 108). Outcome was analyzed using Kaplan–Meier method, log-rank test, and Cox regression models.

Results

Median CRP level was 0.5 mg/dl (0.1–28.3), and median Hb level was 13.4 g/dl (6.7–17.9). Patients with CRP value above the median died significantly earlier due to their disease than those with CRP below the median (median CSS 19 vs. 70 months; p < 0.001). Patients with preoperative Hb level below the median had significantly worse outcome than those with Hb level above the median (median CSS 25 vs. 78 months; p < 0.001). In multivariate analysis, CRP and Hb levels were independent prognostic parameters regarding CSS/OS (CRP p = 0.016/p = 0.004; Hb p = 0.006/p = 0.004, respectively).

Conclusions

In our single-center study, preoperative CRP and Hb levels were found to be independent prognostic factors, indicating impaired outcome in patients undergoing RC for TCC. These findings could be used for individual risk stratification and optimization of therapeutic strategies.
Literature
2.
go back to reference Gschwend JE, Dahm P, Fair WR (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41(4):440–448CrossRefPubMed Gschwend JE, Dahm P, Fair WR (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41(4):440–448CrossRefPubMed
3.
go back to reference Trulson JJ, Sharma P, Haden T, Kheterpal E, Pokala N (2014) Comparative survival following different treatment modalities for stage T2 bladder cancer in octogenarians. World J Urol 32(2):425–429CrossRefPubMed Trulson JJ, Sharma P, Haden T, Kheterpal E, Pokala N (2014) Comparative survival following different treatment modalities for stage T2 bladder cancer in octogenarians. World J Urol 32(2):425–429CrossRefPubMed
4.
go back to reference Psutka SP, Carrasco A, Schmit GD et al (2014) Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer 120:2910–2918CrossRefPubMed Psutka SP, Carrasco A, Schmit GD et al (2014) Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer 120:2910–2918CrossRefPubMed
5.
go back to reference Fussenich LM, Desar IM, Peters ME et al (2011) A new, simple and objective prognostic score for phase I cancer patients. Eur J Cancer 47(8):1152–1160CrossRefPubMed Fussenich LM, Desar IM, Peters ME et al (2011) A new, simple and objective prognostic score for phase I cancer patients. Eur J Cancer 47(8):1152–1160CrossRefPubMed
6.
go back to reference Stein B, Schrader AJ, Wegener G, Seidel C, Kuczyk MA, Steffens S (2013) Preoperative serum C-reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma. BMC Cancer 13:101CrossRefPubMedPubMedCentral Stein B, Schrader AJ, Wegener G, Seidel C, Kuczyk MA, Steffens S (2013) Preoperative serum C-reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma. BMC Cancer 13:101CrossRefPubMedPubMedCentral
7.
go back to reference Morizane S, Iwamoto H, Masago T et al (2013) Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Int Urol Nephrol 45(1):99–106CrossRefPubMed Morizane S, Iwamoto H, Masago T et al (2013) Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Int Urol Nephrol 45(1):99–106CrossRefPubMed
9.
go back to reference Kersten C, Louhimo J, Algars A et al (2013) Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer. Acta Oncol 52(8):1691–1698CrossRefPubMed Kersten C, Louhimo J, Algars A et al (2013) Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer. Acta Oncol 52(8):1691–1698CrossRefPubMed
10.
go back to reference Xu L, Zhao Q, Huang S, Li S, Wang J, Li Q (2014) Serum C-reactive protein acted as a prognostic biomarker for overall survival in metastatic prostate cancer patients. Tumour Biol 36:669–673CrossRefPubMed Xu L, Zhao Q, Huang S, Li S, Wang J, Li Q (2014) Serum C-reactive protein acted as a prognostic biomarker for overall survival in metastatic prostate cancer patients. Tumour Biol 36:669–673CrossRefPubMed
11.
go back to reference Hrab M, Olek-Hrab K, Antczak A, Kwias Z, Milecki T (2013) Interleukin-6 (IL-6) and C-reactive protein (CRP) concentration prior to total nephrectomy are prognostic factors in localized renal cell carcinoma (RCC). Rep Pract Oncol Radiother 18(5):304–309CrossRefPubMedPubMedCentral Hrab M, Olek-Hrab K, Antczak A, Kwias Z, Milecki T (2013) Interleukin-6 (IL-6) and C-reactive protein (CRP) concentration prior to total nephrectomy are prognostic factors in localized renal cell carcinoma (RCC). Rep Pract Oncol Radiother 18(5):304–309CrossRefPubMedPubMedCentral
12.
go back to reference Aziz A, Rink M, Gakis G et al (2014) Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. Urol Int 93(3):352–360CrossRefPubMed Aziz A, Rink M, Gakis G et al (2014) Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. Urol Int 93(3):352–360CrossRefPubMed
13.
go back to reference Fujita K, Uemura M, Yamamoto Y et al (2015) Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. Int J Clin Oncol 20(1):156–6314CrossRefPubMed Fujita K, Uemura M, Yamamoto Y et al (2015) Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. Int J Clin Oncol 20(1):156–6314CrossRefPubMed
14.
go back to reference Tanaka N, Kikuchi E, Shirotake S et al (2014) The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. Eur Urol 65(1):227–234CrossRefPubMed Tanaka N, Kikuchi E, Shirotake S et al (2014) The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. Eur Urol 65(1):227–234CrossRefPubMed
15.
go back to reference Allin KH, Bojesen SE, Nordestgaard BG (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27(13):2217–2224CrossRefPubMed Allin KH, Bojesen SE, Nordestgaard BG (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27(13):2217–2224CrossRefPubMed
16.
go back to reference Heikkila K, Ebrahim S, Lawlor DA (2007) A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 61(9):824–833CrossRefPubMedPubMedCentral Heikkila K, Ebrahim S, Lawlor DA (2007) A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 61(9):824–833CrossRefPubMedPubMedCentral
17.
go back to reference Okamoto M, Hattori K, Oyasu R (1997) Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer 72(1):149–154CrossRefPubMed Okamoto M, Hattori K, Oyasu R (1997) Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer 72(1):149–154CrossRefPubMed
19.
go back to reference DeNardo DG, Johansson M, Coussens LM (2008) Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 27(1):11–18CrossRefPubMed DeNardo DG, Johansson M, Coussens LM (2008) Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 27(1):11–18CrossRefPubMed
20.
go back to reference Weis SM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17(11):1359–1370CrossRefPubMed Weis SM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17(11):1359–1370CrossRefPubMed
21.
22.
go back to reference Cui J, Zhou L, Wee B, Shen F, Ma X, Zhao J (2014) Predicting survival time in noncurative patients with advanced cancer: a prospective study in China. J Palliat Med 17(5):545–552CrossRefPubMedPubMedCentral Cui J, Zhou L, Wee B, Shen F, Ma X, Zhao J (2014) Predicting survival time in noncurative patients with advanced cancer: a prospective study in China. J Palliat Med 17(5):545–552CrossRefPubMedPubMedCentral
23.
go back to reference Gravis G, Boher JM, Fizazi K et al (2015) Prognostic factors for survival in noncastrate metastatic prostate cancer: validation of the glass model and development of a novel simplified prognostic model. Eur Urol 68:196–204CrossRefPubMed Gravis G, Boher JM, Fizazi K et al (2015) Prognostic factors for survival in noncastrate metastatic prostate cancer: validation of the glass model and development of a novel simplified prognostic model. Eur Urol 68:196–204CrossRefPubMed
24.
go back to reference Gaspar BL, Sharma P, Das R (2015) Anemia in malignancies: pathogenetic and diagnostic considerations. Hematology 20(1):18–25CrossRefPubMed Gaspar BL, Sharma P, Das R (2015) Anemia in malignancies: pathogenetic and diagnostic considerations. Hematology 20(1):18–25CrossRefPubMed
25.
go back to reference Langdon JM, Yates SC, Femnou LK et al (2014) Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation. Am J Hematol 89(5):470–479CrossRefPubMedPubMedCentral Langdon JM, Yates SC, Femnou LK et al (2014) Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation. Am J Hematol 89(5):470–479CrossRefPubMedPubMedCentral
26.
go back to reference Icardi A, Sacco P, Tarroni A, Cappelletti L, Cozzolino M (2013) [Role of inflammation on renal anaemia]. Giornale italiano di nefrologia: organo ufficiale della Societa italiana di nefrologia 30(6) Icardi A, Sacco P, Tarroni A, Cappelletti L, Cozzolino M (2013) [Role of inflammation on renal anaemia]. Giornale italiano di nefrologia: organo ufficiale della Societa italiana di nefrologia 30(6)
Metadata
Title
Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study
Authors
T. Grimm
A. Buchner
B. Schneevoigt
A. Kretschmer
M. Apfelbeck
M. Grabbert
J. F. Jokisch
C. G. Stief
A. Karl
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 5/2016
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1680-7

Other articles of this Issue 5/2016

World Journal of Urology 5/2016 Go to the issue